113 related articles for article (PubMed ID: 4112552)
1. [The conservative treatment of prostatic hypertrophy with Paraprost].
Aito K; Watsubo E
Hinyokika Kiyo; 1972 Jan; 18(1):41-4. PubMed ID: 4112552
[No Abstract] [Full Text] [Related]
2. [Clinical effect of PPC for the palliative treatment of benign prostatic hypertrophy].
Ishigami J; Kuroda K
Hinyokika Kiyo; 1969 Jan; 15(1):68-75. PubMed ID: 4180035
[No Abstract] [Full Text] [Related]
3. [Clinical application of "PPC" to prostatic hypertrophy and others].
Sugiura H; Shimaya M
Hinyokika Kiyo; 1969 Jun; 15(6):450-3. PubMed ID: 4185864
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
Maekawa M; Kishimoto T; Yasumoto R; Wada S; Harada T; Ohara T; Okajima E; Hirao Y; Ohzono S; Shimada K
Hinyokika Kiyo; 1990 Apr; 36(4):495-516. PubMed ID: 1696065
[TBL] [Abstract][Full Text] [Related]
5. [BPH pharmacotherapy (miscellaneous)].
Okada H
Nihon Rinsho; 2002 Dec; 60 Suppl 11():367-72. PubMed ID: 12599602
[No Abstract] [Full Text] [Related]
6. Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study.
Yamaguchi O; Shiraiwa Y; Kobayashi M; Yokota T; Ohinata M; Aoki H; Tsuzuki T; Ohori M
Urol Int; 1990; 45 Suppl 1():40-6. PubMed ID: 1690481
[TBL] [Abstract][Full Text] [Related]
7. Palliative treatment of benign prostatic hypertrophy; value of glycine-alanine-glutamic acid combination.
FEINBLATT HM; GANT JC
J Maine Med Assoc; 1958 Mar; 49(3):99-101 passim. PubMed ID: 13514330
[No Abstract] [Full Text] [Related]
8. [Double blind test of PPC for prostatic hyperplasia].
Shimaya M; Sugiura H
Hinyokika Kiyo; 1970 May; 16(5):231-6. PubMed ID: 4194682
[No Abstract] [Full Text] [Related]
9. [Amino acid therapy for hypertrophy of the prostate].
Shiga H; Kumamoto E; Imamura A
Hinyokika Kiyo; 1968 Aug; 14(8):625-32. PubMed ID: 4178205
[No Abstract] [Full Text] [Related]
10. [Clinical study of a phytosterol extract of Prunus arborea and 3 amino acids: glycine, alanine and glutamic acid].
Cuervo Blanco E; Francia Bengoechea A; Fraile Gómez B
Arch Esp Urol; 1978; 31(1):97-8. PubMed ID: 697415
[TBL] [Abstract][Full Text] [Related]
11. [Conservative treatment of prostatic hypertrophy with gestagens].
Baevskiĭ IuL
Urol Nefrol (Mosk); 1974; 39(4):31-3. PubMed ID: 4137390
[No Abstract] [Full Text] [Related]
12. [Use of amino acids as a combination in the treatment of prostatic hypertrophy].
Menéndez Fernández H; Castillo Vergara P; Hilario García Marcos J; Romero Gil JR
Arch Esp Urol; 1988 Sep; 41(7):495-9. PubMed ID: 2468315
[No Abstract] [Full Text] [Related]
13. [Conservative treatment of prostatic adenoma].
Gikov D; Bozhilov I
Khirurgiia (Sofiia); 1974; 27(5):398-403. PubMed ID: 4143140
[No Abstract] [Full Text] [Related]
14. [Prostatilen treatment of prostatic adenoma].
Al'-Shukri SKh; Gorbachev AG; Borovets SIu; Belousov VIa; Kuz'min IV; Chushkin KA
Urologiia; 2006; (6):22, 25-6. PubMed ID: 17315707
[TBL] [Abstract][Full Text] [Related]
15. [Echotomographic evaluation of the recent endocrine trends in the treatment of so-called prostatic hypertrophy].
Napolitano A; Gargano E; Criniti P; Zezza A; Seccia M; Galfano G
Ann Ital Chir; 1983; 55(2):161-7. PubMed ID: 6197917
[No Abstract] [Full Text] [Related]
16. [Use of Eviprostat for treatment of prostatic hypertrophy].
Ookita K; Shiraga T; Matsumura Y
Hinyokika Kiyo; 1966 May; 12(5):511-7. PubMed ID: 4164092
[No Abstract] [Full Text] [Related]
17. [Treatment of prostatic hypertrophy with depostat].
Nuri M; Hochberg K
Munch Med Wochenschr; 1970 May; 112(22):1057-60. PubMed ID: 4192989
[No Abstract] [Full Text] [Related]
18. [Doxazosin in the treatment of benign prostatic hypertrophy].
Rollema HJ; Janknegt RA
J Urol (Paris); 1993; 99(6):314-5. PubMed ID: 7516377
[No Abstract] [Full Text] [Related]
19. [Treatment of prostatic hypertrophy with eviprostat].
Kubo Y; Inoue S; Ono T; Yasui A
Hinyokika Kiyo; 1966 Dec; 12(12):1463-7. PubMed ID: 4167083
[No Abstract] [Full Text] [Related]
20. [The treatment of patients with benign prostatic hyperplasia with Proscar MSD (finasteride)].
Stepanov VN; Teodorovich OV; Seregin AV; Kadyrov ZA
Urol Nefrol (Mosk); 1995; (5):28-30. PubMed ID: 8571480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
